Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

NCT01147042 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Stopped Early termination due to only 2 subjects completing trial.

Conditions

IFN-Gamma Therapy
CGD Gene Mutation
CGD Response to IFNg
CGD - Chronic Granulomatous Disease
Immunodeficiency Disease

Interventions

DRUG: IFN-gamma

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)